TABLE 7.

Bayesian analysis of visual function in RP patients after 2 years of the nutritional supplementation.

Bayesian analysis at baseline	ES	95% CrI	Pr of PLC < NUT	ROPE	Pr of PLC > NUT	P-value
Visual outcomes (both eyes)
P1 amplitude (Σ Q1–Q4)	−0.180	−0.365; −0.004	0.923	0.071	0.006	0.041
Implicit time-mfERG	−0.350	−4.790; 4.140	0.151	0.756	0.093	0.840
VF	−0.139	−0.702; 0.417	0.465	0.396	0.137	0.601
Retinal thickness (SD-OCT) (Mean R1–R9)	−1.210	−6.480; 4.110	0.037	0.961	0.003	0.305

ES, estimate; Crl, credible interval; Pr, probability; RP, patients with retinitis pigmentosa; C, controls; ROPE, region of practical equivalence; mfERG, multifocal electroretinography; VF, visual field; SD-OCT, spectral domain-optical coherence tomography.